Plavix 75mg Tablet
PDF Leaflet Revision Date: 16 August 2018
Clinical Summary
Quick overview from the medicine insert
Indication
Reduction of atherothrombotic events.
Dosage (summary)
75 mg once daily; 300 mg loading dose for acute coronary syndrome.
Onset of Action / Duration
Onset: 2 hours, Duration: 7 days
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy; not recommended during breastfeeding.
Key Drug Interactions
- Acetylsalicylic acid
- Warfarin
- NSAIDs
- SSRIs
Contraindications
- Hypersensitivity
- Active bleeding
- Severe liver impairment
- Thrombocytopenia
Common side effects
- Bleeding
- Dyspepsia
- Abdominal pain
- Bruising
Counselling Points
- Report unusual bleeding
- Discontinue 7 days before surgery
- Inform healthcare providers of clopidogrel use
Serious warnings
- Thrombotic Thrombocytopenic Purpura (TTP)
- Increased bleeding risk
Important Disclaimer
The Plavix 75mg Tablet professional information leaflet below is the property of Sanofi-Synthelabo and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
